Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alopecia | 2 | 2024 | 412 | 1.260 |
Why?
|
Spondylosis | 2 | 2017 | 84 | 1.070 |
Why?
|
Negotiating | 2 | 2024 | 150 | 1.040 |
Why?
|
Surgicenters | 1 | 2024 | 50 | 0.940 |
Why?
|
Minoxidil | 1 | 2024 | 34 | 0.910 |
Why?
|
Spinal Cord Diseases | 2 | 2017 | 292 | 0.910 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2019 | 491 | 0.900 |
Why?
|
Spinal Cord Neoplasms | 2 | 2016 | 263 | 0.890 |
Why?
|
Aerosols | 3 | 2021 | 635 | 0.880 |
Why?
|
Head and Neck Neoplasms | 6 | 2019 | 2895 | 0.860 |
Why?
|
Finasteride | 1 | 2024 | 86 | 0.860 |
Why?
|
Cervical Vertebrae | 3 | 2017 | 980 | 0.800 |
Why?
|
Medicare | 9 | 2023 | 6770 | 0.770 |
Why?
|
Platelet-Rich Plasma | 1 | 2024 | 178 | 0.760 |
Why?
|
Reimbursement, Incentive | 3 | 2021 | 543 | 0.740 |
Why?
|
Medicare Part B | 1 | 2022 | 117 | 0.740 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2019 | 4026 | 0.710 |
Why?
|
Hypoglossal Nerve | 2 | 2022 | 108 | 0.670 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.660 |
Why?
|
Otolaryngology | 4 | 2020 | 693 | 0.660 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2020 | 324 | 0.640 |
Why?
|
Spinal Fractures | 2 | 2015 | 705 | 0.640 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.640 |
Why?
|
Cochlear Implantation | 1 | 2023 | 316 | 0.620 |
Why?
|
Hospital Charges | 1 | 2020 | 350 | 0.620 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2019 | 198 | 0.620 |
Why?
|
Cochlear Implants | 1 | 2023 | 339 | 0.610 |
Why?
|
Electric Stimulation Therapy | 2 | 2022 | 628 | 0.580 |
Why?
|
Neck Dissection | 1 | 2019 | 201 | 0.570 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2019 | 242 | 0.560 |
Why?
|
Outsourced Services | 1 | 2016 | 20 | 0.560 |
Why?
|
Neurosurgical Procedures | 3 | 2018 | 2072 | 0.550 |
Why?
|
Quality of Life | 9 | 2023 | 13367 | 0.550 |
Why?
|
Surgery, Plastic | 1 | 2023 | 643 | 0.540 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.530 |
Why?
|
Tracheostomy | 1 | 2020 | 426 | 0.530 |
Why?
|
Morpholines | 1 | 2019 | 581 | 0.520 |
Why?
|
Specialties, Surgical | 1 | 2020 | 389 | 0.520 |
Why?
|
Thoracic Vertebrae | 2 | 2017 | 597 | 0.500 |
Why?
|
Facial Paralysis | 3 | 2023 | 346 | 0.480 |
Why?
|
Disclosure | 1 | 2020 | 748 | 0.470 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.470 |
Why?
|
Decompression, Surgical | 2 | 2016 | 607 | 0.460 |
Why?
|
Endoscopy | 3 | 2020 | 1851 | 0.430 |
Why?
|
Lumbar Vertebrae | 3 | 2017 | 1879 | 0.430 |
Why?
|
Thrombospondins | 3 | 2020 | 193 | 0.430 |
Why?
|
Pyrroles | 1 | 2019 | 1125 | 0.420 |
Why?
|
Parkinson Disease | 2 | 2017 | 2877 | 0.410 |
Why?
|
Health Care Costs | 3 | 2023 | 3242 | 0.410 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.400 |
Why?
|
Motivation | 2 | 2021 | 2006 | 0.380 |
Why?
|
Astrocytoma | 1 | 2016 | 775 | 0.380 |
Why?
|
Home Care Services | 1 | 2017 | 648 | 0.370 |
Why?
|
Spinal Fusion | 2 | 2017 | 1286 | 0.360 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2022 | 1875 | 0.350 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26127 | 0.340 |
Why?
|
Surgery, Computer-Assisted | 1 | 2017 | 1007 | 0.320 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2630 | 0.320 |
Why?
|
Costs and Cost Analysis | 3 | 2023 | 1668 | 0.320 |
Why?
|
Piperazines | 1 | 2019 | 2523 | 0.310 |
Why?
|
United States | 19 | 2024 | 72335 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3086 | 0.310 |
Why?
|
Retrospective Studies | 26 | 2023 | 80646 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3206 | 0.300 |
Why?
|
Humans | 67 | 2024 | 761572 | 0.300 |
Why?
|
Lymph Nodes | 1 | 2019 | 3466 | 0.300 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1613 | 0.290 |
Why?
|
Multiple Myeloma | 2 | 2015 | 5146 | 0.290 |
Why?
|
Telemedicine | 2 | 2022 | 3052 | 0.280 |
Why?
|
Ossification, Heterotopic | 2 | 2018 | 235 | 0.260 |
Why?
|
Databases, Factual | 2 | 2019 | 7967 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3205 | 0.220 |
Why?
|
Insurance, Health | 3 | 2022 | 2498 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.220 |
Why?
|
Fees and Charges | 1 | 2024 | 192 | 0.220 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2024 | 112 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.210 |
Why?
|
Middle Aged | 25 | 2023 | 220920 | 0.200 |
Why?
|
Biological Products | 2 | 2022 | 914 | 0.200 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.200 |
Why?
|
Relative Value Scales | 2 | 2020 | 84 | 0.200 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2024 | 395 | 0.200 |
Why?
|
Facial Nerve Injuries | 1 | 2022 | 64 | 0.200 |
Why?
|
Cisplatin | 2 | 2019 | 1652 | 0.200 |
Why?
|
Hospitals | 4 | 2023 | 3882 | 0.200 |
Why?
|
Male | 30 | 2024 | 360842 | 0.200 |
Why?
|
Female | 33 | 2024 | 392686 | 0.190 |
Why?
|
Voice Quality | 2 | 2020 | 226 | 0.190 |
Why?
|
Cosmetic Techniques | 1 | 2023 | 149 | 0.190 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2915 | 0.190 |
Why?
|
Aged | 20 | 2023 | 169310 | 0.180 |
Why?
|
Adenoidectomy | 1 | 2022 | 167 | 0.180 |
Why?
|
Hypersensitivity | 2 | 2021 | 1171 | 0.180 |
Why?
|
Voice Training | 1 | 2020 | 44 | 0.180 |
Why?
|
Legislation as Topic | 1 | 2020 | 77 | 0.180 |
Why?
|
Leuprolide | 1 | 2022 | 312 | 0.180 |
Why?
|
Compensation and Redress | 1 | 2020 | 66 | 0.180 |
Why?
|
Olfactory Mucosa | 1 | 2021 | 101 | 0.180 |
Why?
|
Survival Rate | 3 | 2019 | 12725 | 0.180 |
Why?
|
Cautery | 1 | 2020 | 71 | 0.170 |
Why?
|
Fee Schedules | 1 | 2020 | 87 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10194 | 0.170 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 483 | 0.170 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 464 | 0.170 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11121 | 0.170 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 97 | 0.170 |
Why?
|
Baculoviridae | 1 | 2019 | 115 | 0.160 |
Why?
|
Anti-Anxiety Agents | 1 | 2022 | 397 | 0.160 |
Why?
|
Radiation Injuries | 2 | 2017 | 1189 | 0.160 |
Why?
|
Suction | 1 | 2020 | 266 | 0.160 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13642 | 0.160 |
Why?
|
Marketing of Health Services | 1 | 2020 | 151 | 0.160 |
Why?
|
Caspase 8 | 1 | 2019 | 190 | 0.160 |
Why?
|
Hair | 1 | 2022 | 498 | 0.160 |
Why?
|
Treatment Outcome | 10 | 2023 | 64684 | 0.160 |
Why?
|
Cordotomy | 1 | 2018 | 7 | 0.150 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 935 | 0.150 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2019 | 192 | 0.150 |
Why?
|
Rhinoplasty | 1 | 2022 | 238 | 0.150 |
Why?
|
Dysphonia | 1 | 2020 | 144 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 507 | 0.150 |
Why?
|
Paranasal Sinuses | 1 | 2020 | 265 | 0.150 |
Why?
|
Failed Back Surgery Syndrome | 1 | 2017 | 20 | 0.150 |
Why?
|
Cost Control | 1 | 2020 | 628 | 0.140 |
Why?
|
Nasopharynx | 1 | 2020 | 401 | 0.140 |
Why?
|
Radiosurgery | 2 | 2017 | 1342 | 0.140 |
Why?
|
State Government | 1 | 2020 | 384 | 0.140 |
Why?
|
Radiation Tolerance | 1 | 2019 | 479 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 316 | 0.140 |
Why?
|
Temporal Bone | 2 | 2018 | 683 | 0.140 |
Why?
|
Medicare Part D | 1 | 2021 | 355 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 243 | 0.140 |
Why?
|
Tongue | 1 | 2020 | 403 | 0.140 |
Why?
|
Nasal Polyps | 1 | 2022 | 395 | 0.130 |
Why?
|
Nose | 1 | 2020 | 521 | 0.130 |
Why?
|
Cost Savings | 2 | 2021 | 913 | 0.130 |
Why?
|
Cohort Studies | 6 | 2019 | 41493 | 0.130 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 121 | 0.130 |
Why?
|
Laryngoscopy | 2 | 2020 | 707 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1611 | 0.130 |
Why?
|
Cough | 1 | 2020 | 594 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2644 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2018 | 15633 | 0.130 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1722 | 0.130 |
Why?
|
Spondylolisthesis | 1 | 2017 | 175 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8552 | 0.120 |
Why?
|
Vocal Cords | 1 | 2020 | 522 | 0.120 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 278 | 0.120 |
Why?
|
Radiography | 2 | 2015 | 6965 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 667 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 272 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20571 | 0.120 |
Why?
|
Surgical Flaps | 1 | 2023 | 1671 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2017 | 390 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2021 | 631 | 0.110 |
Why?
|
Rhinitis | 1 | 2022 | 747 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1784 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3603 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1468 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 549 | 0.110 |
Why?
|
Pandemics | 4 | 2020 | 8656 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1597 | 0.110 |
Why?
|
Bone Screws | 1 | 2017 | 532 | 0.110 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1962 | 0.110 |
Why?
|
Apoptosis | 3 | 2019 | 9489 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 564 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22173 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1119 | 0.110 |
Why?
|
Patient Readmission | 2 | 2017 | 3271 | 0.110 |
Why?
|
Polysomnography | 1 | 2020 | 1848 | 0.110 |
Why?
|
Electrodes, Implanted | 1 | 2017 | 840 | 0.100 |
Why?
|
Fluoroscopy | 1 | 2017 | 947 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5336 | 0.100 |
Why?
|
Sinusitis | 1 | 2022 | 991 | 0.100 |
Why?
|
Adult | 14 | 2023 | 221203 | 0.100 |
Why?
|
Cardiology | 1 | 2023 | 1656 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5872 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1376 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1126 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1913 | 0.100 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1204 | 0.100 |
Why?
|
Pain Measurement | 2 | 2018 | 3551 | 0.090 |
Why?
|
Facial Nerve | 2 | 2023 | 277 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1492 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 16986 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 495 | 0.090 |
Why?
|
Hospitalists | 1 | 2014 | 294 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 601 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 937 | 0.090 |
Why?
|
Reoperation | 2 | 2017 | 4303 | 0.080 |
Why?
|
Spinal Cord Injuries | 1 | 2017 | 925 | 0.080 |
Why?
|
Hospitals, Pediatric | 2 | 2016 | 1860 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2023 | 3461 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1570 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6815 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1315 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2917 | 0.080 |
Why?
|
Spine | 1 | 2015 | 1118 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1993 | 0.080 |
Why?
|
Disease Progression | 2 | 2015 | 13510 | 0.080 |
Why?
|
Medical Errors | 1 | 2017 | 1263 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1367 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3627 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4352 | 0.070 |
Why?
|
Patient Discharge | 2 | 2017 | 3443 | 0.070 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1265 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8528 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29629 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39107 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3708 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10090 | 0.070 |
Why?
|
Length of Stay | 2 | 2017 | 6426 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10448 | 0.070 |
Why?
|
Cadaver | 2 | 2020 | 1358 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9031 | 0.060 |
Why?
|
Comorbidity | 2 | 2020 | 10508 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4431 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1940 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1756 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 54426 | 0.050 |
Why?
|
Mice | 6 | 2020 | 81533 | 0.050 |
Why?
|
Smiling | 1 | 2023 | 72 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2491 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15266 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9053 | 0.050 |
Why?
|
Denervation | 1 | 2023 | 265 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7213 | 0.050 |
Why?
|
Middle Ear Ventilation | 1 | 2022 | 101 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3600 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10773 | 0.050 |
Why?
|
Stroboscopy | 1 | 2020 | 62 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23996 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2017 | 7879 | 0.040 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2023 | 506 | 0.040 |
Why?
|
Brain | 2 | 2017 | 27120 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 283 | 0.040 |
Why?
|
Ohio | 1 | 2020 | 322 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18253 | 0.040 |
Why?
|
Smell | 1 | 2021 | 259 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11742 | 0.040 |
Why?
|
Animals | 6 | 2020 | 168467 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39970 | 0.040 |
Why?
|
Karnofsky Performance Status | 1 | 2017 | 166 | 0.040 |
Why?
|
Perception | 1 | 2023 | 1197 | 0.040 |
Why?
|
Head | 1 | 2023 | 924 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 74213 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 718 | 0.030 |
Why?
|
Otologic Surgical Procedures | 1 | 2018 | 150 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2021 | 448 | 0.030 |
Why?
|
Health Facilities | 1 | 2021 | 580 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2016 | 162 | 0.030 |
Why?
|
District of Columbia | 1 | 2016 | 159 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1648 | 0.030 |
Why?
|
Pregnancy | 1 | 2018 | 29876 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9319 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22172 | 0.030 |
Why?
|
Chick Embryo | 1 | 2017 | 982 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12059 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
Osteotomy | 1 | 2018 | 837 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1814 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13255 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1459 | 0.020 |
Why?
|
Gene Amplification | 1 | 2016 | 1089 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18965 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 58986 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4001 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2897 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8830 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2366 | 0.020 |
Why?
|
Spinal Cord | 1 | 2017 | 1819 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3088 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2605 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1836 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36429 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4573 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6344 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4111 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2057 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5769 | 0.020 |
Why?
|
Child | 3 | 2022 | 80156 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14416 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5205 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26198 | 0.020 |
Why?
|
Infant | 2 | 2016 | 36192 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15732 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12463 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 42230 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8124 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11076 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9326 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15843 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 59255 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11904 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6346 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5315 | 0.010 |
Why?
|
Melanoma | 1 | 2016 | 5709 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 88324 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10721 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23447 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13382 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21017 | 0.010 |
Why?
|